Cargando…
SUN-LB87 De-Novo Graves Ophthalmopathy After Total Thyroidectomy With Exacerbation Following Rifampicin Therapy for Latent Tuberculosis: A Call for Attention to Disease Modifying Interventions
Introduction Factors influencing development and course of ophthalmopathy, the most common extrathyroidal manifestation of Graves’ disease, remain poorly defined. Clinical Case A 46 year old healthy, non-smoking, medical secretary, presented with Graves’ disease. Laboratory investigation showed thyr...
Autores principales: | Shaklai, Sigal, Marcus-Perlman, Yonit, Klein, Ainat, Stern, Naftali, Greenman, Yona |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208773/ http://dx.doi.org/10.1210/jendso/bvaa046.2230 |
Ejemplares similares
-
SUN-LB76 Euthyroid Ophthalmopathy in Coexistence With Differential Thyroid Carcinoma
por: Garate, Dioni, et al.
Publicado: (2020) -
SUN-568 Steroid Induced Psychosis Complicating the Treatment of Graves Ophthalmopathy
por: Babu, Leeba, et al.
Publicado: (2019) -
SUN-LB097 Thyroid Hormone Resistance Simulating Graves Disease
por: Ballestas-Revollo, Martha, et al.
Publicado: (2019) -
FRI553 ICI-induced Thyroid Ophthalmopathy With De Novo Graves’ Disease
por: Moctezuma, Sananda I, et al.
Publicado: (2023) -
SAT-LB101 Sclerosing Mucoepidermoid Carcinoma with Eosinophilia (SMECE) of the Thyroid: Benign Long Term Course with Conservative Treatment in a High Risk Thyroid Cancer
por: Marcus, Yonit, et al.
Publicado: (2019)